AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Medpace Holdings, Inc. Common Stock
XNAS · usd
SIC 8731 · SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
FIGI BBG0065B7K40
669.20▲ 15.24 (2.33%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
—
Trailing P/E
Price / Sales
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
—
Trading Information
Previous Close
653.96
Day's Range
645.93 – 670.18
52-Week Range
372.95 – 684.52
Volume
306.8K
Avg Volume
306.4K
Share Statistics
Shares Outstanding
Employees
6,300
Exchange
XNAS
Listed
2016-08-11
Share count as of October 16, 2026

Medpace Holdings, Inc. Common Stock (MEDP) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Medpace Holdings, Inc. Common Stock (MEDP)
What is Medpace Holdings, Inc. Common Stock's Market Cap?
Medpace Holdings, Inc. Common Stock's Market Cap is $18.7B, based on as-reported figures from SEC (XBRL) filings.
What is Medpace Holdings, Inc. Common Stock's Trailing P/E?
Medpace Holdings, Inc. Common Stock's Trailing P/E is 36.1×, based on as-reported figures from SEC (XBRL) filings.
What is Medpace Holdings, Inc. Common Stock's Price / Sales?
Medpace Holdings, Inc. Common Stock's Price / Sales is 6.6×, based on as-reported figures from SEC (XBRL) filings.
What is Medpace Holdings, Inc. Common Stock's Revenue (TTM)?
Medpace Holdings, Inc. Common Stock's Revenue (TTM) is $2.8B, based on as-reported figures from SEC (XBRL) filings.
What is Medpace Holdings, Inc. Common Stock's Net Income (TTM)?
Medpace Holdings, Inc. Common Stock's Net Income (TTM) is $517.8M, based on as-reported figures from SEC (XBRL) filings.
What is Medpace Holdings, Inc. Common Stock's EBITDA?
Medpace Holdings, Inc. Common Stock's EBITDA is $634.5M, based on as-reported figures from SEC (XBRL) filings.
What is Medpace Holdings, Inc. Common Stock's Diluted EPS (TTM)?
Medpace Holdings, Inc. Common Stock's Diluted EPS (TTM) is 18.51, based on as-reported figures from SEC (XBRL) filings.
What is Medpace Holdings, Inc. Common Stock's EBITDA Margin?
Medpace Holdings, Inc. Common Stock's EBITDA Margin is 22.4%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · MEDPAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in millions of USD, except per-share data)
Source: Akyla.ai
Line ItemSep 30, 2026Jun 30, 2026Mar 31, 2026Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022
Revenue, net (includes $3.8 million and $12.2 million with related parties for the three months ended September 30, 2026 and 2025, respectively, and $15.8 million and $42.9 million with related parties for the nine months ended September 30, 2026 and 2025, respectively)
YoY growth+18.7%+26.6%+31.7%
Operating expenses:
Total direct costs
Selling, general and administrative
Depreciation
Amortization
Total operating expenses
% of revenue76.9%79.2%80.0%
Income from operations
% of revenue23.1%20.8%20.0%
Other income, net:
Miscellaneous income (expense), net
Interest income, net
Total other income, net
Income before income taxes
Income tax provision
Net income
% of revenue19.2%17.2%17.5%
Net income per share attributable to common shareholders:
Basic (in dollars per share)
Diluted (in dollars per share)